A nurse is teaching about food choices to a client who has chronic kidney disease and must limit potassium intake.

Which of the following choices should the nurse recommend as containing the least potassium?

• A. "You should ask your provider about your plan." This response is appropriate because it acknowledges the client's desire to explore alternative treatments while directing them to the appropriate source for medical advice. It promotes client autonomy and ensures they receive accurate information from their healthcare provider.
• B. "Tell me what you know about chemotherapy." This response is also appropriate. It encourages the client to express their understanding and concerns about chemotherapy, allowing the nurse to identify any misconceptions and provide accurate information. This also opens the door for the client to express their concerns about vitamins and minerals, and why they want to persue that treatment.
• C. "I have never heard of any holistic treatment that is effective." This response is inappropriate because it dismisses the client's preferences and demonstrates a lack of respect for their autonomy. It also displays a lack of knowledge, as some holistic treatments can be used as supportive therapies.
• D. "The best way to treat your cancer is chemotherapy." This response is inappropriate because it is directive and does not allow the client to participate in decision-making. It also does not address the client's desire to explore alternative treatments.

Lithium. Lithium is a medication that has been associated with an increased risk of developing diabetes insipidus. This is because lithium can interfere with the function of the kidneys and their ability to respond to antidiuretic hormone (ADH), which regulates the balance of fluids in the body.
Atorvastatin (choice B) is a medication used to lower cholesterol levels and has not been associated with an increased risk of diabetes insipidus.
Propranolol (choice A) is a beta-blocker used to treat high blood pressure and heart conditions and has not been associated with an increased risk of diabetes insipidus.
Ranitidine (choice C) is a medication used to reduce stomach acid production and has not been associated with an increased risk of diabetes insipidus.